SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO)

CUSIP: 834203309

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
51,293,400
Total 13F shares
4,852,710
Share change
+1,781,073
Total reported value
$20,757,863
Price per share
$4.29
Number of holders
22
Value change
+$7,837,293
Number of buys
6
Number of sells
9

Security key

834203309

Report period

Q2 2023

Institutions

22

Top holders

10

Top shareholders of SLNO - SOLENO THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Carlyle Group Inc.
13F
Company
2.3%
1,201,506
$2,535,178 31 Mar 2023
13F
Nantahala Capital Management, LLC
13F
Company
1.4%
699,364
$1,496,639 31 Mar 2023
13F
AIGH Capital Management LLC
13F
Company
0.82%
422,489
$904,127 31 Mar 2023
13F
J. Goldman & Co LP
13F
Company
0.53%
269,443
$576,608 31 Mar 2023
13F
Worth Venture Partners, LLC
13F
Company
0.2%
103,913
$222,374 31 Mar 2023
13F
Clayton Partners LLC
13F
Company
0.18%
92,772
$198,532 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.15%
76,515
$164,000 31 Mar 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
69,869
$150,000 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
0.1%
49,939
$106,869 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
32,556
$69,669 31 Mar 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
30,139
$64,497 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.03%
15,448
$33,059 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
2,814
$6,000 31 Mar 2023
13F
Bollard Group LLC
13F
Company
0%
2,288
$5,000 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
2,093
$4,479 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
0%
342
$731 31 Mar 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
71
$152 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
38
$81 31 Mar 2023
13F
GROUP ONE TRADING LLC
13F
Company
0%
37
$79 31 Mar 2023
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
1
$2 31 Mar 2023
13F
Abingworth LLP
3/4/5
10%+ Owner
mixed-class rows
25,774,464
mixed-class rows
$657,560,041 21 Dec 2018
Jack W. Schuler
3/4/5
10%+ Owner
class O/S missing
36,595
$1,335,180 09 Dec 2022
Birchview Capital, LP
13F
Company
class O/S missing
245,127
$525,000 31 Mar 2023
13F
Gwen A. Melincoff
3/4/5
Director
class O/S missing
10,000
25 May 2023

Institutional Holders of SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) as of Q2 2023

As of 30 Jun 2023, SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,852,710 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Carlyle Group Inc., Nantahala Capital Management, LLC, AIGH Capital Management LLC, J. Goldman & Co LP, Worth Venture Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and DIMENSIONAL FUND ADVISORS LP. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
20
Q2 2023 holders
22
Holder diff
2
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .